These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1676557)

  • 1. Beneficial effect of long-term beta blockade after acute myocardial infarction in patients without anterograde flow in the infarct artery.
    Glamann DB; Lange RA; Hillis LD
    Am J Cardiol; 1991 Jul; 68(2):150-4. PubMed ID: 1676557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of collateral filling of the occluded infarct-related coronary artery on prognosis after acute myocardial infarction.
    Boehrer JD; Lange RA; Willard JE; Hillis LD
    Am J Cardiol; 1992 Jan; 69(1):10-2. PubMed ID: 1729856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after acute myocardial infarction in patients with and without residual anterograde coronary blood flow.
    Cigarroa RG; Lange RA; Hillis LD
    Am J Cardiol; 1989 Jul; 64(3):155-60. PubMed ID: 2741824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of anterograde flow in the infarct artery on the incidence of late potentials after acute myocardial infarction.
    Lange RA; Cigarroa RG; Wells PJ; Kremers MS; Hills LD
    Am J Cardiol; 1990 Mar; 65(9):554-8. PubMed ID: 2309626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early infarct artery collateral flow does not improve long-term survival following thrombolytic therapy for acute myocardial infarction.
    Nicolau JC; Nogueira PR; Pinto MA; Serrano CV; Garzon SA
    Am J Cardiol; 1999 Jan; 83(1):21-6. PubMed ID: 10073779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
    Koenig W; Löwel H; Lewis M; Hörmann A
    Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of long-term use of a beta-blocker in patients before acute myocardial infarction.
    Bortolotto LA; Ramires JA; Serrano Junior CV; Cesar LA; Solimene MC; da-Luz PL; Pileggi F
    Braz J Med Biol Res; 1995 Jun; 28(6):637-42. PubMed ID: 8547845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of renin-angiotensin system inhibitors on long-term survival in patients treated with beta blockers and antiplatelet agents after acute myocardial infarction (from the MONICA/KORA Myocardial Infarction Registry).
    Amann U; Kirchberger I; Heier M; Zirngibl A; von Scheidt W; Kuch B; Peters A; Meisinger C
    Am J Cardiol; 2014 Aug; 114(3):329-35. PubMed ID: 24927969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocker in post-myocardial infarct survivors with preserved left ventricular systolic function.
    Siu CW; Pong V; Jim MH; Yue WS; Ho HH; Li SW; Lau CP; Tse HF
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):675-80. PubMed ID: 20132502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of infarct-related artery patency and late potentials on late mortality after acute myocardial infarction.
    Kawalsky DL; Garratt KN; Hammill SC; Bailey KR; Gersh BJ
    Mayo Clin Proc; 1997 May; 72(5):414-21. PubMed ID: 9146682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of late reopening of the infarct-related artery on left ventricular remodelling after myocardial infarction. IRIS Study Group.
    Meneveau N; Bassand JP; Bauters C; Rozand JY; Petit JL; Beurrier D; Grollier G; Andre F; Vahanian A; Viel JF
    Eur Heart J; 1997 Aug; 18(8):1261-8. PubMed ID: 9458418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of coronary blood flow in the infarct-related artery after intracoronary progenitor cell therapy: intracoronary Doppler substudy of the TOPCARE-AMI trial.
    Schächinger V; Assmus B; Honold J; Lehmann R; Hofmann WK; Martin H; Dimmeler S; Zeiher AM
    Clin Res Cardiol; 2006 Jan; 95(1):13-22. PubMed ID: 16598441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Blockade and acute myocardial infarction.
    Lie KI; Fiolet JW
    Eur Heart J; 1983 Jul; 4 Suppl D():167-71. PubMed ID: 6137379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of global and regional left ventricular function by percutaneous transluminal coronary angioplasty after myocardial infarction.
    Miketić S; Carlsson J; Tebbe U
    J Am Coll Cardiol; 1995 Mar; 25(4):843-7. PubMed ID: 7884086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitation of infarct size by beta blockers and its potential role for prognosis.
    Hjalmarson A; Herlitz J
    Circulation; 1983 Jun; 67(6 Pt 2):I68-71. PubMed ID: 6133646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
    Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
    Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined receptor intervention and myocardial infarction.
    Chamberlain DA; Vincent R
    Drugs; 1984; 28 Suppl 2():88-108. PubMed ID: 6151893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ; Muhlestein JB; Bair TL; Renlund DG; Lappé DL; Jensen KR; Horne BD; Carter MA; Anderson JL;
    Am J Cardiol; 2005 Apr; 95(7):827-31. PubMed ID: 15781009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.